HomeRCE • ASX
add
Recce Pharmaceuticals Ltd
Previous close
$0.41
Day range
$0.41 - $0.45
Year range
$0.28 - $0.56
Market cap
118.57M AUD
Avg Volume
89.45K
P/E ratio
-
Dividend yield
-
Primary exchange
ASX
Market news
Financials
Income Statement
Revenue
Net income
| (AUD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 281.26K | -78.75% |
Operating expense | 5.92M | 18.41% |
Net income | -6.85M | -34.25% |
Net profit margin | -2.43K | -531.70% |
Earnings per share | — | — |
EBITDA | -6.65M | -36.56% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (AUD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 10.69M | 142.02% |
Total assets | 12.41M | 94.90% |
Total liabilities | 15.47M | -2.69% |
Total equity | -3.05M | — |
Shares outstanding | 288.37M | — |
Price to book | -41.00 | — |
Return on assets | -134.23% | — |
Return on capital | -215.97% | — |
Cash Flow
Net change in cash
| (AUD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -6.85M | -34.25% |
Cash from operations | -6.76M | -108.25% |
Cash from investing | -17.99K | 78.14% |
Cash from financing | 11.03M | 212.34% |
Net change in cash | 4.25M | 1,991.60% |
Free cash flow | -3.71M | -17.64% |
About
CEO
Founded
Apr 11, 2007
Website
